Children Acetaminophen Oral Solution
FDA Label NDC 17856-7014

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Atlantic Biologicals Corp. for the product Children Acetaminophen Oral Solution (NDC 17856-7014). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding otc - active ingredient, otc - purpose, indications & usage, warnings, otc - pregnancy or breast feeding, otc - keep out of reach of children, dosage & administration, inactive ingredient, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Otc - Active Ingredient

Active ingredient (per 5 mL teaspoonful)

Acetaminophen 160 mg

Otc - Purpose

Purpose

Pain Reliever/Fever Reducer

Indications & Usage

Uses

  • temporarily relieves minor aches and pains due to:
  • headache
  • muscular aches
  • backache
  • minor pain of arthritis
  • the common cold
  • toothache
  • premenstrual and menstrual cramps
  • temporarily reduces fever

Warnings

Warnings

Liver Warning: This product contains acetaminophen. Severe liver damage may occur if:

  • adult takes more than 6 doses in 24 hours, which is the maximum daily amount
  • child takes more than 5 doses in 24 hours, which is the maximum daily amount
  • taken with other drugs containing acetaminophen
  • adult has 3 or more alcoholic drinks everyday while using this product
  • Allergy alert: acetaminophen may cause severe skin reactions. Symptoms may include:

    • skin reddening
    • blisters
    • rash
    • If a skin reaction occurs, stop use and seek medical help right away.

      Do not use with any other drug containing acetaminophen (prescription or nonprescription). If you are not sure whether a drug contains acetaminophen, ask a doctor or pharmacist.

      Ask a doctor before use if you have liver disease.

      Ask a doctor before use if you are taking the blood thinning drug warfarin.

      When using this product: Do not exceed recommended dose.

      Stop use and ask a doctor if

      • pain gets worse or lasts more than 10 days in adults
      • pain gets worse or lasts more than 5 days in children under 12 years
      • fever gets worse or lasts more than 3 days
      • new symptoms occur
      • redness or swelling is present. These could be signs of a serious condition.

Otc - Pregnancy Or Breast Feeding

If pregnant or breast-feeding, ask a health professional before use

Otc - Keep Out Of Reach Of Children

Keep out of reach of children. In case of overdose, get medical help or contact a Paoison Control Center right away. Quick medical attention is critical for adults/children even if you do not notice any signs or symptoms.

Dosage & Administration

Directions

  • do not take more than directed
  • find dose in chart below
  • if possible, use weight to dose, otherwise use age
  • dosage may be repeasted every 4 hours, or as directed by a doctor
  • do not give more than 5 doses in 24 hours
  •  Weight (lbs) under 24 24-35 36-4748-59  60-71 72-95 over 95
    Age (years)  under 2 2 to 3 4 to 5 6 to 8 9 to 10 11 12 to adult
    Dosage Teaspoonful (tsp)  consult Physician 1 tsp (5 mL) 1 1/2 tsp (7.5 mL) 2 tsp (10 mL) 2 1/2 tsp (12.5 mL) 3 tsp (15 mL) 4 tsp (20 mL)

Inactive Ingredient

Inactive ingredients: artificial and natural cherry flavor, citric acid, FD&C Red #40, methylparaben, polyethylene glycol, propylene glycol, propylparaben, purified water, sodium citrate, sucralose

Package Label.Principal Display Panel

Image 1 (17856 7014 01)

Image 1 (17856 7014 01)

Image 2 (17856 7014 03)

Image 2 (17856 7014 03)

Image 3 (17856 7014 04)

Image 3 (17856 7014 04)

Image 4 (17856 7014 06)

Image 4 (17856 7014 06)

Image 5 (17856 7014 07)

Image 5 (17856 7014 07)

Image 6 (17856 7014 08)

Image 6 (17856 7014 08)

* Please review the disclaimer below.